Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,101 to 2,120 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy. | Basic Res Cardiol | 2018 | 30446837 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction. | Biochem J | 2018 | 30446606 | PubTator, text mining | PubMed |
| Ventricular Fibrillation Cardiac Arrest in African American Male with Apical Hypertrophic Cardiomyopathy. | Cureus | 2018 | 30430056 | PubTator, text mining | PubMed |
| Cardiac Resynchronization Therapy-Pacemaker Implantation Guided by Three-Dimensional Electroanatomic Mapping for a Chinese Young Man with Danon Disease. | Chin Med J (Engl) | 2018 | 30425207 | PubTator, text mining | PubMed |
| Altered Ca2+ and Na+ Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis. | Front Physiol | 2018 | 30420810 | PubTator, text mining | PubMed |
| Mutation profile of FLNC gene and its prognostic relevance in patients with hypertrophic cardiomyopathy. | Mol Genet Genomic Med | 2018 | 30411535 | PubTator, text mining | PubMed |
| Anhedonia in cocaine use disorder is associated with inflammatory gene expression. | PLoS One | 2018 | 30408130 | PubTator, text mining | PubMed |
| The genetics of hypertrophic cardiomyopathy. | Glob Cardiol Sci Pract | 2018 | 30393648 | PubTator, text mining | PubMed |
| Perspectives on current recommendations for genetic testing in HCM. | Glob Cardiol Sci Pract | 2018 | 30393635 | PubTator, text mining | PubMed |
| Histopathology in HCM. | Glob Cardiol Sci Pract | 2018 | 30393632 | PubTator, text mining | PubMed |
| Clinical presentations of hypertrophic cardiomyopathy and implications for therapy. | Glob Cardiol Sci Pract | 2018 | 30393631 | PubTator, text mining | PubMed |
| The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results. | Mayo Clin Proc | 2018 | 30392543 | PubTator, text mining | PubMed |
| Are We Getting Closer to Risk Stratification in Left Ventricular Noncompaction Cardiomyopathy? | J Am Heart Assoc | 2018 | 30371282 | PubTator, text mining | PubMed |
| Genotype-Positive Status Is Associated With Poor Prognoses in Patients With Left Ventricular Noncompaction Cardiomyopathy. | J Am Heart Assoc | 2018 | 30371277 | PubTator, text mining | PubMed |
| Impact of the Myosin Modulator Mavacamten on Force Generation and Cross-Bridge Behavior in a Murine Model of Hypercontractility. | J Am Heart Assoc | 2018 | 30371160 | PubTator, text mining | PubMed |
| Disparities in the Diagnosis of Hypertrophic Obstructive Cardiomyopathy: A Narrative Review of Current Literature. | Cardiol Res Pract | 2018 | 30370151 | PubTator, text mining | PubMed |
| Left Ventricular Trabeculations in Athletes: Epiphenomenon or Phenotype of Disease? | Curr Treat Options Cardiovasc Med | 2018 | 30367273 | PubTator, text mining | PubMed |
| N-terminal extension in cardiac myosin-binding protein C regulates myofilament binding. | J Mol Cell Cardiol | 2018 | 30359561 | PubTator, text mining | PubMed |
| Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus. | Biosci Rep | 2018 | 30355653 | PubTator, text mining | PubMed |
| Basic Cardiovascular Sciences Scientific Sessions 2018. | Circ Res | 2018 | 30355166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=106